» Articles » PMID: 19448641

A HUPO Test Sample Study Reveals Common Problems in Mass Spectrometry-based Proteomics

Overview
Journal Nat Methods
Date 2009 May 19
PMID 19448641
Citations 132
Authors
Affiliations
Soon will be listed here.
Abstract

We performed a test sample study to try to identify errors leading to irreproducibility, including incompleteness of peptide sampling, in liquid chromatography-mass spectrometry-based proteomics. We distributed an equimolar test sample, comprising 20 highly purified recombinant human proteins, to 27 laboratories. Each protein contained one or more unique tryptic peptides of 1,250 Da to test for ion selection and sampling in the mass spectrometer. Of the 27 labs, members of only 7 labs initially reported all 20 proteins correctly, and members of only 1 lab reported all tryptic peptides of 1,250 Da. Centralized analysis of the raw data, however, revealed that all 20 proteins and most of the 1,250 Da peptides had been detected in all 27 labs. Our centralized analysis determined missed identifications (false negatives), environmental contamination, database matching and curation of protein identifications as sources of problems. Improved search engines and databases are needed for mass spectrometry-based proteomics.

Citing Articles

Standard operating procedure combined with comprehensive quality control system for multiple LC-MS platforms urinary proteomics.

Liu X, Sun H, Hou X, Sun J, Tang M, Zhang Y Nat Commun. 2025; 16(1):1051.

PMID: 39865094 PMC: 11770173. DOI: 10.1038/s41467-025-56337-4.


Proteomic Profiling Towards a Better Understanding of Genetic Based Muscular Diseases: The Current Picture and a Look to the Future.

Pauper M, Hentschel A, Tiburcy M, Beltran S, Ruck T, Schara-Schmidt U Biomolecules. 2025; 15(1).

PMID: 39858524 PMC: 11763865. DOI: 10.3390/biom15010130.


Reference Materials for Improving Reliability of Multiomics Profiling.

Ren L, Shi L, Zheng Y Phenomics. 2024; 4(5):487-521.

PMID: 39723231 PMC: 11666855. DOI: 10.1007/s43657-023-00153-7.


Assessing and mitigating batch effects in large-scale omics studies.

Yu Y, Mai Y, Zheng Y, Shi L Genome Biol. 2024; 25(1):254.

PMID: 39363244 PMC: 11447944. DOI: 10.1186/s13059-024-03401-9.


Proteomics appending a complementary dimension to precision oncotherapy.

Zhou Z, Zhang R, Zhou A, Lv J, Chen S, Zou H Comput Struct Biotechnol J. 2024; 23:1725-1739.

PMID: 38689716 PMC: 11058087. DOI: 10.1016/j.csbj.2024.04.044.


References
1.
Carr S, Aebersold R, Baldwin M, Burlingame A, Clauser K, Nesvizhskii A . The need for guidelines in publication of peptide and protein identification data: Working Group on Publication Guidelines for Peptide and Protein Identification Data. Mol Cell Proteomics. 2004; 3(6):531-3. DOI: 10.1074/mcp.T400006-MCP200. View

2.
Au C, Bell A, Gilchrist A, Hiding J, Nilsson T, Bergeron J . Organellar proteomics to create the cell map. Curr Opin Cell Biol. 2007; 19(4):376-85. DOI: 10.1016/j.ceb.2007.05.004. View

3.
Keller A, Nesvizhskii A, Kolker E, Aebersold R . Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem. 2002; 74(20):5383-92. DOI: 10.1021/ac025747h. View

4.
Gilchrist A, Au C, Hiding J, Bell A, Fernandez-Rodriguez J, Lesimple S . Quantitative proteomics analysis of the secretory pathway. Cell. 2006; 127(6):1265-81. DOI: 10.1016/j.cell.2006.10.036. View

5.
Strausberg R, Feingold E, Klausner R, Collins F . The mammalian gene collection. Science. 1999; 286(5439):455-7. DOI: 10.1126/science.286.5439.455. View